MedTrace Logo

Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma

NCT00051532 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 700

Last updated 2025-02-25

No results posted yet for this study

Summary

The purpose of the study is to determine whether seocalcitol is effective in the treatment of advanced primary liver cancer (hepatocellular carcinoma \[HCC\]).

Conditions

  • Liver Neoplasms

Interventions

DRUG

Seocalcitol

Sponsors & Collaborators

  • LEO Pharma

    lead INDUSTRY

Principal Investigators

  • Hanne Hvidberg, MSc Pharm, PhD · LEO Pharma

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-09-30
Completion
2004-05-31

Countries

  • Canada
  • France
  • Italy
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00051532 on ClinicalTrials.gov